ACR 2026 Preview: CAR-T, Emerging Immune Therapies and AI in Rheumatology
ACR 2026 at a glance The ACR 2026 Annual Meeting will highlight developments in…
Immunology Today—July 1, 2026
This week’s Immunology update highlights regulatory decisions, clinical trial…
Immunology Today—June 3, 2026
This week’s Immunology update highlights regulatory and clinical developments…
EULAR 2026 Preview: Competitive Shifts in Rheumatology
EULAR 2026 at a glance EULAR 2026 highlights a potential shift in rheumatology…
Immunology Today—May 13, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…
Immunology Today—March 18, 2026
This week’s Immunology update highlights regulatory progress, late-stage…
Immunology Video Recap—March 11, 2026
This biweekly Immunology video recap highlights regulatory approvals,…
Immunology Today—March 11, 2026
This week’s Immunology update highlights regulatory progress, positive…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
EADV 2025 Preview: Dermatology and Venereology Highlights to Watch
EADV 2025 at a Glance Ahead of EADV 2025, LucidQuest highlights…
Immunology Weekly News - July 30th 2025
🧬 Immunology Updates: Major moves in myasthenia gravis, Crohn’s, psoriasis,…